> top > docs > PMC:7589163 > spans > 52509-53871 > annotations

PMC:7589163 / 52509-53871 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T274 53-64 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738
T275 125-142 Body_part denotes respiratory tract http://purl.org/sig/ont/fma/fma265130
T276 479-492 Body_part denotes bronchiolitis http://purl.org/sig/ont/fma/fma76497
T277 682-705 Body_part denotes lower respiratory tract http://purl.org/sig/ont/fma/fma45662
T278 1211-1216 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T279 1332-1355 Body_part denotes lower respiratory tract http://purl.org/sig/ont/fma/fma45662

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T95 125-142 Body_part denotes respiratory tract http://purl.obolibrary.org/obo/UBERON_0000065
T96 682-705 Body_part denotes lower respiratory tract http://purl.obolibrary.org/obo/UBERON_0001558
T97 688-705 Body_part denotes respiratory tract http://purl.obolibrary.org/obo/UBERON_0000065
T98 1211-1216 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T99 1332-1355 Body_part denotes lower respiratory tract http://purl.obolibrary.org/obo/UBERON_0001558
T100 1338-1355 Body_part denotes respiratory tract http://purl.obolibrary.org/obo/UBERON_0000065

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T203 125-153 Disease denotes respiratory tract infections http://purl.obolibrary.org/obo/MONDO_0024355
T204 169-175 Disease denotes asthma http://purl.obolibrary.org/obo/MONDO_0004979
T205 479-492 Disease denotes bronchiolitis http://purl.obolibrary.org/obo/MONDO_0002465
T206 920-926 Disease denotes asthma http://purl.obolibrary.org/obo/MONDO_0004979
T207 1314-1324 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T520 286-290 http://purl.obolibrary.org/obo/CLO_0001757 denotes at 1
T521 361-362 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T522 394-399 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T523 457-458 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T524 479-492 http://purl.obolibrary.org/obo/UBERON_0002186 denotes bronchiolitis
T525 682-705 http://purl.obolibrary.org/obo/UBERON_0001558 denotes lower respiratory tract
T526 728-730 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T527 781-782 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T528 850-851 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T529 1211-1216 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T530 1211-1216 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T531 1296-1297 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T532 1332-1355 http://purl.obolibrary.org/obo/UBERON_0001558 denotes lower respiratory tract

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T58954 45-64 Chemical denotes omega-3 fatty acids http://purl.obolibrary.org/obo/CHEBI_25681
T5515 53-64 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T92728 59-64 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T72908 203-206 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T8053 394-399 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T90045 637-640 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T81148 1060-1064 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T36825 1066-1069 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T16119 1070-1073 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005
T91570 1199-1202 Chemical denotes EPA http://purl.obolibrary.org/obo/CHEBI_28364
T48796 1207-1210 Chemical denotes DHA http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T97 125-153 Phenotype denotes respiratory tract infections http://purl.obolibrary.org/obo/HP_0011947
T98 155-163 Phenotype denotes wheezing http://purl.obolibrary.org/obo/HP_0030828
T99 169-175 Phenotype denotes asthma http://purl.obolibrary.org/obo/HP_0002099
T100 479-492 Phenotype denotes bronchiolitis http://purl.obolibrary.org/obo/HP_0011950
T101 920-926 Phenotype denotes asthma http://purl.obolibrary.org/obo/HP_0002099

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T321 0-176 Sentence denotes Some studies investigated the effects of the omega-3 fatty acids supplementation on infant morbidity, particularly caused by respiratory tract infections, wheezing, and asthma.
T322 177-343 Sentence denotes Imhoff et al. showed that DHA supplementation during pregnancy decreased the occurrence of colds in children at 1 month and influenced illness symptom duration [213].
T323 344-566 Sentence denotes Pastor et al. in a multicenter, prospective, open-label observational study, which included 1342 infants, showed a higher incidence of bronchiolitis in control versus groups who received omega-3-supplemented formula [214].
T324 567-780 Sentence denotes In contrast, in another study aimed to valuate the effect of neonatal DHA supplementation, the hospitalisation for lower respiratory tract problems in the first 18 months for preterm infants was not reduced [215].
T325 781-1115 Sentence denotes A randomized controlled, trial which included 736 pregnant women and a total of 695 children, showed that the risk of persistent wheeze or asthma was reduced by approximately 7% in the first 5 years of life among children of women who received daily supplementation with omega−3 PUFA (EPA/DHA) during the third trimester of pregnancy.
T326 1116-1241 Sentence denotes It is notable that this effect was most prominent among children of women with low EPA and DHA blood levels at randomization.
T327 1242-1362 Sentence denotes Furthermore, supplementation was also associated with a reduced risk of infections of the lower respiratory tract [216].

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1347 277-285 Species denotes children Tax:9606
1348 441-448 Species denotes infants Tax:9606
1349 750-757 Species denotes infants Tax:9606
1350 840-845 Species denotes women Tax:9606
1351 865-873 Species denotes children Tax:9606
1352 994-1002 Species denotes children Tax:9606
1353 1006-1011 Species denotes women Tax:9606
1354 1172-1180 Species denotes children Tax:9606
1355 1184-1189 Species denotes women Tax:9606
1356 688-699 Species denotes respiratory Tax:12814
1357 1338-1349 Species denotes respiratory Tax:12814
1358 45-64 Chemical denotes omega-3 fatty acids MESH:D015525
1359 203-206 Chemical denotes DHA MESH:C027493
1360 531-538 Chemical denotes omega-3
1361 637-640 Chemical denotes DHA MESH:C027493
1362 1052-1064 Chemical denotes omega−3 PUFA
1363 1070-1073 Chemical denotes DHA MESH:C027493
1364 1207-1210 Chemical denotes DHA MESH:C027493
1365 125-153 Disease denotes respiratory tract infections MESH:D012141
1366 169-175 Disease denotes asthma MESH:D001249
1367 479-492 Disease denotes bronchiolitis MESH:D001988
1368 920-926 Disease denotes asthma MESH:D001249
1369 1314-1324 Disease denotes infections MESH:D007239